Bromocriptine Protects Dopaminergic Neurons from Levodopa-Induced Toxicity by Stimulating D2Receptors

This publication has 50 references indexed in Scilit:

• Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up
  Acta Neurologica Scandinavica, 2009
• Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary cultures
  Neuroscience Letters, 1997
• Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from fisher 344 and Sprague-Dawley donors
  Cell Transplantation, 1997
• Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination
  Journal of Neuroscience Research, 1993
• Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamine
  Movement Disorders, 1993
• Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures
  Experimental Neurology, 1991
• Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo
  European Journal of Pharmacology, 1991
• Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues
  Brain Research, 1991
• 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway
  Nature, 1986